Diligence memo · auto-generated · as of July 2, 2026
Protege Biomedical, LLC
Protege Biomedical, LLC looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Protege Biomedical, LLC operates in Biotechnology, based in EDEN PRAIRIE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Protege Biomedical, LLC has raised $1.1M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $600K on 2018-01-03.
Most recent recorded round closed around 2019-02-25.
Valuation (modeled)modeled
Provath models Protege Biomedical, LLC at approximately $9.7M (range $93K–$110M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.62× the median modeled value of Pre-Seed Biotechnology companies in 2019–2021 (156 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 7.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 3.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 19% of Biotechnology peers (4293 compared).
Modeled value ranks above 18% of those peers.
Closest niche peers: Crimson BioPharm Inc., Pinpoint Therapeutics Inc., Transplant Logistics & Informatics Llc, RNAissance AG LLC, Pylum Biosciences, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.